Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL
Xuehai Bian, Zhongxing Liang, Amber Feng, et al.
Biochemical Pharmacology (2017) Vol. 147, pp. 30-37
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Towards targeting of shared mechanisms of cancer metastasis and therapy resistance
Felix Weiß, Douglas A. Lauffenburger, Peter Friedl
Nature reviews. Cancer (2022) Vol. 22, Iss. 3, pp. 157-173
Open Access | Times Cited: 189
Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia
Shasha Ren, Jiuzhou Liu, Yun Feng, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 155
Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents
Meran Keshawa Ediriweera, Kamani Hemamala Tennekoon, Sameera R. Samarakoon
Drug Discovery Today (2019) Vol. 24, Iss. 3, pp. 685-702
Closed Access | Times Cited: 80
<p>Resistance and Overcoming Resistance in Breast Cancer</p>
Andrea Luque-Bolivar, Erika Pérez-Mora, Victoria Eugenia Villegas, et al.
Breast Cancer Targets and Therapy (2020) Vol. Volume 12, pp. 211-229
Open Access | Times Cited: 78
Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside
María J. Pajares, Ester Alemany-Cosme, Saioa Goñi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7350-7350
Open Access | Times Cited: 60
Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
Zhen Li, Wei Zou, Ji Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 63
Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors
Pierre Autin, Christophe Blanquart, Delphine Fradin
Cancers (2019) Vol. 11, Iss. 10, pp. 1530-1530
Open Access | Times Cited: 51
Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease
Amal Qattan
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 8905-8905
Open Access | Times Cited: 45
Paxillin family of focal adhesion adaptor proteins and regulation of cancer cell invasion
Kyle M. Alpha, Weiyi Xu, Christopher E. Turner
International review of cell and molecular biology (2020), pp. 1-52
Open Access | Times Cited: 37
Decoding the Epigenome of Breast Cancer
Elisa Cortellesi, Isabella Savini, M Veneziano, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2605-2605
Open Access
CUDC‑907 reverses pathological phenotype of keloid fibroblasts in vitro and in vivo via dual inhibition of PI3K/Akt/mTOR signaling and HDAC2
Tian Tu, Jia Huang, Miaomiao Lin, et al.
International Journal of Molecular Medicine (2019)
Open Access | Times Cited: 33
The Many Faces of Gene Regulation in Cancer: A Computational Oncogenomics Outlook
Enrique Hernández-Lemus, Helena Reyes-Gopar, Jesús Espinal‐Enríquez, et al.
Genes (2019) Vol. 10, Iss. 11, pp. 865-865
Open Access | Times Cited: 31
Targeting miRNAs by histone deacetylase inhibitors (HDACi): Rationalizing epigenetics-based therapies for breast cancer
Meran Keshawa Ediriweera, Somi Kim Cho
Pharmacology & Therapeutics (2019) Vol. 206, pp. 107437-107437
Closed Access | Times Cited: 30
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics
Maxime Janin, Verónica Dávalos, Manel Esteller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1071-1112
Open Access | Times Cited: 9
The Significance of Regulatory MicroRNAs: Their Roles in Toxicodynamics of Mycotoxins and in the Protection Offered by Dietary Therapeutics Against Mycotoxin-Induced Toxicity
Xue Rong, Dongxiao Sun‐Waterhouse, Dan Wang, et al.
Comprehensive Reviews in Food Science and Food Safety (2018) Vol. 18, Iss. 1, pp. 48-66
Open Access | Times Cited: 30
Epigenetic alterations impede epithelial-mesenchymal transition by modulating centrosome amplification and Myc/RAS axis in triple negative breast cancer cells
Laxmidhar Das
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
MicroRNAs and Metastasis
Carla Solé, Charles H. Lawrie
Cancers (2019) Vol. 12, Iss. 1, pp. 96-96
Open Access | Times Cited: 21
HDAC inhibitor sodium butyrate prevents allergic rhinitis and alters lncRNA and mRNA expression profiles in the nasal mucosa of mice
Jie Wang, Mu Cui, Fei Sun, et al.
International Journal of Molecular Medicine (2020)
Open Access | Times Cited: 20
MicroRNAs involved in drug resistance of breast cancer by regulating autophagy
Nan Wen, Qing Lv, Zhenggui Du
Journal of Zhejiang University SCIENCE B (2020) Vol. 21, Iss. 9, pp. 690-702
Open Access | Times Cited: 19
Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
Jun Sheng Wong, Yoke Kqueen Cheah
Non-Coding RNA (2020) Vol. 6, Iss. 3, pp. 29-29
Open Access | Times Cited: 18
An antioxidant ameliorates allergic airway inflammation by inhibiting HDAC 1 via HIF-1α/VEGF axis suppression in mice
Ramiya Islam, Debabrata Dash, Rashmi Singh
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Moscatilin Suppresses the Breast Cancer Both In Vitro and In Vivo by Inhibiting HDAC3
Wenjie Su, Lianfu Zeng, Weida Chen
Dose-Response (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 15
Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2‐dependent pathway
Danhui Liu, Yuzhen Liu, Bo Qi, et al.
Cancer Medicine (2021) Vol. 10, Iss. 15, pp. 5235-5245
Open Access | Times Cited: 14
Circular RNA circ_0000741/miR-379-5p/TRIM14 signaling axis promotes HDAC inhibitor (SAHA) tolerance in glioblastoma
Liang Meng, Yuefei Wang, Qin Tu, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 4, pp. 1351-1364
Closed Access | Times Cited: 5
Retracted: Anticancer effects of miR‐200c in colorectal cancer through BMI1
Mitra Karimi Mazraehshah, Seyed Mohammad Tavangar, Massoud Saidijam, et al.
Journal of Cellular Biochemistry (2018) Vol. 119, Iss. 12, pp. 10005-10012
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top